Skip to main content

Dan Roden

Grants spur effort to add genetic data to EMR

Sep. 10, 2015—Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records.

Read more


VUMC lands major pharmacogenomics grant

Jul. 9, 2015—Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.

Read more


Task force named to prioritize Academic Strategic Plan health initiatives

May. 7, 2015—A new faculty task force has been appointed to prioritize and refine the eight health-related initiatives in the Academic Strategic Plan and to inventory existing health-related interdisciplinary centers and institutes at Vanderbilt.

Read more


Workshop explores President’s Precision Medicine Initiative

Feb. 19, 2015—The Precision Medicine Initiative is a national effort announced by President Obama during his State of the Union address to provide more effective treatment and prevention strategies for individuals by taking into account their unique genetic, environmental and lifestyle factors.

Read more


Roden named to NIH’s genomics advisory council

Jun. 12, 2014—Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH).

Read more


Transplant drug added to PREDICT program

Aug. 15, 2013—Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.

Read more


Clinical Pharmacology celebrates 50th anniversary

Jun. 13, 2013—Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.

Read more


Record number elected AAAS fellows

Nov. 29, 2012—Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.

Read more


Balser, Roden discuss personalized medicine at Global South Summit

Nov. 15, 2012—“Personalized medicine—the effort to tailor health care to understand individual patients’ needs, genetic profiles and circumstances—is a big emphasis at the Vanderbilt University Medical Center,” said Jeff Balser, vice chancellor for health affairs and dean of the School of Medicine at Vanderbilt, in his opening statement to a panel discussing personalized medicine at the Global South Summit...

Read more


Heart Association honors Roden’s research efforts

Nov. 15, 2012—Dan Roden, M.D., assistant vice chancellor for Personalized Medicine and William Stokes Professor of Experimental Therapeutics, received a 2012 Distinguished Scientist Award at the annual Scientific Sessions of the American Heart Association (AHA) last week in Los Angeles.

Read more


AAMC meet highlights need for research funds

Sep. 27, 2012—During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research.

Read more


Dan Roden: “Genomes, Hype, and a Realistic Pathway to Personalized Medicine”

Sep. 12, 2012—Watch video of the Chancellor’s Lecture Series, featuring a talk by Dr. Dan Roden: “Genomes, Hype, and a Realistic Pathway to Personalized Medicine” Roden is widely-recognized for his expertise in clinical, genetic, cellular, and molecular basis of arrhythmia susceptibility and variability responses to arrhythmia therapies. Over the past decade, he has led Vanderbilt’s broader efforts in...

Read more


VIEW MORE EVENTS >